The EspF effector, a bacterial pathogen's swiss army knife

Infection and Immunity

Volumn 78, Issue 11, 2010, Pages 4445-4453

  Holmes, Ashleigh ^a   Mühlen, Sabrina ^b   Roe, Andrew J ^a   Dean, Paul ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; ESCHERICHIA COLI PROTEIN; GLUTATHIONE TRANSFERASE; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PROTEIN ESPF; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MEMBRANE; CITROBACTER RODENTIUM; COMPETITIVE INHIBITION; CYTOSKELETON; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM; HOST CELL; HUMAN; INFECTIOUS DIARRHEA; INTERMEDIATE FILAMENT; INTESTINE CELL; MICROVILLUS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOLUS; PHAGOCYTOSIS; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RIBOSOME; SHORT SURVEY; TARGET CELL; TIGHT JUNCTION;

CARRIER PROTEINS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; ESCHERICHIA COLI PROTEINS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MITOCHONDRIA; VIRULENCE;

EID: 78049422962     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00635-10     Document Type: Short Survey

References (59)

1. Alto, N. M., A. W. Weflen, M. J. Rardin, D. Yarar, C. S. Lazar, R. Tonikian, A. Koller, S. S. Taylor, C. Boone, S. S. Sidhu, S. L. Schmid, G. A. Hecht, and J. E. Dixon. 2007. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol. 178:1265-1278.
2. Boisvert, F. M., S. van Koningsbruggen, J. Navascues, and A. I. Lamond. 2007. The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 8:574-585.
3. Campellone, K. G., H. C. Cheng, D. Robbins, A. D. Siripala, E. J. McGhie, R. D. Hayward, M. D. Welch, M. K. Rosen, V. Koronakis, and J. M. Leong. 2008. Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly. PLoS Pathog. 4:e1000191.
4. Campellone, K. G., D. Robbins, and J. M. Leong. 2004. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev. Cell 7:217-228.
5. Canil, C., I. Rosenshine, S. Ruschkowski, M. S. Donnenberg, J. B. Kaper, and B. B. Finlay. 1993. Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infect. Immun. 61:2755-2762.
6. Celli, J., M. Olivier, and B. B. Finlay. 2001. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20:1245-1258.
7. Charpentier, X., and E. Oswald. 2004. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J. Bacteriol. 186:5486-5495.
8. Crane, J. K., S. Majumdar, and D. F. Pickhardt III. 1999. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect. Immun. 67:2575-2584.
9. Crane, J. K., B. P. McNamara, and M. S. Donnenberg. 2001. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell. Microbiol. 3:197-211.
10. Dean, P., and B. Kenny. 2009. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
11. Dean, P., and B. Kenny. 2004. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54:665-675.
12. Dean, P., M. Maresca, S. Schuller, A. D. Phillips, and B. Kenny. 2006. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl. Acad. Sci. U. S. A. 103:1876-1881.
13. Dean, P., S. Muhlen, S. Quitard, and B. Kenny. 2010. The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector. Cell. Microbiol. 12:1308-1321.
14. Dean, P., J. A. Scott, A. A. Knox, S. Quitard, N. J. Watkins, and B. Kenny. 2010. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction. PLoS Pathog. 6:e1000961.
15. Deng, W., J. L. Puente, S. Gruenheid, Y. Li, B. A. Vallance, A. Vazquez, J. Barba, J. A. Ibarra, P. O'Donnell, P. Metalnikov, K. Ashman, S. Lee, D. Goode, T. Pawson, and B. B. Finlay. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101:3597-3602.
16. Elliott, S. J., C. B. O'Connell, A. Koutsouris, C. Brinkley, M. S. Donnenberg, G. Hecht, and J. B. Kaper. 2002. A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF. Infect. Immun. 70:2271-2277.
17. Frankel, G., and A. D. Phillips. 2008. Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell. Microbiol. 10:549-556.
18. Garmendia, J., A. D. Phillips, M. F. Carlier, Y. Chong, S. Schuller, O. Marches, S. Dahan, E. Oswald, R. K. Shaw, S. Knutton, and G. Frankel. 2004. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell. Microbiol. 6:1167-1183.
19. Guttman, J. A., and B. B. Finlay. 2008. Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol. 16:535-542.
20. Guttman, J. A., Y. Li, M. E. Wickham, W. Deng, A. W. Vogl, and B. B. Finlay. 2006. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell. Microbiol. 8:634-645.
21. Guttman, J. A., F. N. Samji, Y. Li, W. Deng, A. Lin, and B. B. Finlay. 2007. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell. Microbiol. 9:131-141.
22. Hardwidge, P. R., S. Donohoe, R. Aebersold, and B. B. Finlay. 2006. Proteomic analysis of the binding partners to enteropathogenic Escherichia coli virulence proteins expressed in Saccharomyces cerevisiae. Proteomics 6:2174-2179.
23. Hemrajani, C., C. N. Berger, K. S. Robinson, O. Marches, A. Mousnier, and G. Frankel. 2010. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U. S. A. 107:3129-3134.
24. Hodges, K., N. M. Alto, K. Ramaswamy, P. K. Dudeja, and G. Hecht. 2008. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell. Microbiol. 10:1735-1745.
25. Kelly, M., E. Hart, R. Mundy, O. Marches, S. Wiles, L. Badea, S. Luck, M. Tauschek, G. Frankel, R. M. Robins-Browne, and E. L. Hartland. 2006. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74:2328-2337.
26. Kenny, B., and M. Jepson. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell. Microbiol. 2:579-590.
27. Kenny, B., and R. Valdivia. 2009. Host-microbe interactions: bacteria. Curr. Opin. Microbiol. 12:1-3.
28. Ma, C., M. E. Wickham, J. A. Guttman, W. Deng, J. Walker, K. L. Madsen, K. Jacobson, W. A. Vogl, B. B. Finlay, and B. A. Vallance. 2006. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell. Microbiol. 8:1669-1686.
29. Marches, O., M. Batchelor, R. K. Shaw, A. Patel, N. Cummings, T. Nagai, C. Sasakawa, S. R. Carlsson, R. Lundmark, C. Cougoule, E. Caron, S. Knutton, I. Connerton, and G. Frankel. 2006. EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J. Bacteriol. 188:3110-3115.
30. Marches, O., V. Covarelli, S. Dahan, C. Cougoule, P. Bhatta, G. Frankel, and E. Caron. 2008. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell. Microbiol. 10:1104-1115.
31. Marches, O., J. P. Nougayrede, S. Boullier, J. Mainil, G. Charlier, I. Raymond, P. Pohl, M. Boury, J. De Rycke, A. Milon, and E. Oswald. 2000. Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect. Immun. 68:2171-2182.
32. Martinez-Argudo, I., C. Sands, and M. A. Jepson. 2007. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. Cell. Microbiol. 9:1538-1546.
33. Mayer, B. J. 2001. SH3 domains: complexity in moderation. J. Cell Sci. 114:1253-1263.
34. McNamara, B. P., and M. S. Donnenberg. 1998. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol. Lett. 166:71-78.
35. McNamara, B. P., A. Koutsouris, C. B. O'Connell, J. P. Nougayrede, M. S. Donnenberg, and G. Hecht. 2001. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107:621-629.
36. Meinild, A., D. A. Klaerke, D. D. Loo, E. M. Wright, and T. Zeuthen. 1998. The human Na+-glucose cotransporter is a molecular water pump. J. Physiol. 508:15-21. (Pubitemid 28167566)
37. Mills, E., K. Baruch, X. Charpentier, S. Kobi, and I. Rosenshine. 2008. Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3:104-113. (Pubitemid 351201782)
38. Mundy, R., C. Jenkins, J. Yu, H. Smith, and G. Frankel. 2004. Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. J. Med. Microbiol. 53:1145-1149.
39. Muto, T., T. Obita, Y. Abe, T. Shodai, T. Endo, and D. Kohda. 2001. NMR identification of the Tom20 binding segment in mitochondrial presequences. J. Mol. Biol. 306:137-143.
40. Nagai, T., A. Abe, and C. Sasakawa. 2005. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 280:2998-3011.
41. Neupert, W. 1997. Protein import into mitochondria. Annu. Rev. Biochem. 66:863-917.
42. Nougayrede, J. P., and M. S. Donnenberg. 2004. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 6:1097-1111.
43. Nougayrede, J. P., G. H. Foster, and M. S. Donnenberg. 2007. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell. Microbiol. 9:680-693.
44. Padrick, S. B., H. C. Cheng, A. M. Ismail, S. C. Panchal, L. K. Doolittle, S. Kim, B. M. Skehan, J. Umetani, C. A. Brautigam, J. M. Leong, and M. K. Rosen. 2008. Hierarchical regulation of WASP/WAVE proteins. Mol. Cell 32:426-438.
45. Peralta-Ramirez, J., J. M. Hernandez, R. Manning-Cela, J. Luna-Munoz, C. Garcia-Tovar, J. P. Nougayrede, E. Oswald, and F. Navarro-Garcia. 2008. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect. Immun. 76:3854-3868.
46. Philpott, D. J., D. M. McKay, P. M. Sherman, and M. H. Perdue. 1996. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am. J. Physiol. 270:G634-G645.
47. Quitard, S., P. Dean, M. Maresca, and B. Kenny. 2006. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell. Microbiol. 8:972-981.
48. Ritchie, J. M., and M. K. Waldor. 2005. The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect. Immun. 73:1466-1474.
49. Shaw, R. K., J. Cleary, M. S. Murphy, G. Frankel, and S. Knutton. 2005. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect. Immun. 73:1243-1251.
50. Shull, G. E., M. L. Miller, and P. J. Schultheis. 2000. Lessons from genetically engineered animal models. VIII. Absorption and secretion of ions in the gastrointestinal tract. Am. J. Physiol. Gastrointest Liver Physiol. 278:G185-G190.
51. Spears, K. J., A. J. Roe, and D. L. Gally. 2006. A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol. Lett. 255:187-202.
52. Spitz, J., R. Yuhan, A. Koutsouris, C. Blatt, J. Alverdy, and G. Hecht. 1995. Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am. J. Physiol. 268:G374-G379.
53. Thanabalasuriar, A., A. Koutsouris, A. Weflen, M. Mimee, G. Hecht, and S. Gruenheid. 2010. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell. Microbiol. 12:31-41.
54. Tomson, F. L., V. K. Viswanathan, K. J. Kanack, R. P. Kanteti, K. V. Straub, M. Menet, J. B. Kaper, and G. Hecht. 2005. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol. Microbiol. 56:447-464.
55. Torchinsky, M. B., J. Garaude, A. P. Martin, and J. M. Blander. 2009. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458:78-82.
56. Vallance, B. A., W. Deng, K. Jacobson, and B. B. Finlay. 2003. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71:3443-3453.
57. Viswanathan, V. K., S. Lukic, A. Koutsouris, R. Miao, M. M. Muza, and G. Hecht. 2004. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Cell. Microbiol. 6:987-997.
58. Viswanathan, V. K., A. Weflen, A. Koutsouris, J. L. Roxas, and G. Hecht. 2008. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G1165-G1170.
59. Weflen, A. W., N. M. Alto, V. K. Viswanathan, and G. Hecht. 2010. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism. Cell. Microbiol. 12:919-929.